Exploiting tumour hypoxia in cancer treatment
Solid tumours contain regions at very low oxygen concentrations (hypoxia), often
surrounding areas of necrosis. The cells in these hypoxic regions are resistant to both …
surrounding areas of necrosis. The cells in these hypoxic regions are resistant to both …
Nitroreductase gene-directed enzyme prodrug therapy: insights and advances toward clinical utility
This review examines the vast catalytic and therapeutic potential offered by type I (ie oxygen-
insensitive) nitroreductase enzymes in partnership with nitroaromatic prodrugs, with …
insensitive) nitroreductase enzymes in partnership with nitroaromatic prodrugs, with …
Local bacteria affect the efficacy of chemotherapeutic drugs
P Lehouritis, J Cummins, M Stanton, CT Murphy… - Scientific reports, 2015 - nature.com
In this study, the potential effects of bacteria on the efficacy of frequently used
chemotherapies was examined. Bacteria and cancer cell lines were examined in vitro and in …
chemotherapies was examined. Bacteria and cancer cell lines were examined in vitro and in …
[HTML][HTML] Targeted ablation of beta cells in the embryonic zebrafish pancreas using E. coli nitroreductase
H Pisharath, JM Rhee, MA Swanson, SD Leach… - Mechanisms of …, 2007 - Elsevier
In order to generate a zebrafish model of β cell regeneration, we have expressed an
Escherichia coli gene called nfsB in the β cells of embryonic zebrafish. This bacterial gene …
Escherichia coli gene called nfsB in the β cells of embryonic zebrafish. This bacterial gene …
Design of anticancer prodrugs for reductive activation
Y Chen, L Hu - Medicinal research reviews, 2009 - Wiley Online Library
Anticancer prodrugs designed to target specifically tumor cells should increase therapeutic
effectiveness and decrease systemic side effects in the treatment of cancer. Over the last 20 …
effectiveness and decrease systemic side effects in the treatment of cancer. Over the last 20 …
Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104
Purpose: Hypoxia is a characteristic of solid tumors and a potentially important therapeutic
target. Here, we characterize the mechanism of action and preclinical antitumor activity of a …
target. Here, we characterize the mechanism of action and preclinical antitumor activity of a …
Induction of osteoblast apoptosis stimulates macrophage efferocytosis and paradoxical bone formation
L Batoon, AJ Koh, SM Millard, J Grewal, FM Choo… - Bone Research, 2024 - nature.com
Apoptosis is crucial for tissue homeostasis and organ development. In bone, apoptosis is
recognized to be a main fate of osteoblasts, yet the relevance of this process remains …
recognized to be a main fate of osteoblasts, yet the relevance of this process remains …
Suicide genes for cancer therapy
D Portsmouth, J Hlavaty, M Renner - Molecular aspects of medicine, 2007 - Elsevier
The principle of using suicide genes for gene directed enzyme prodrug therapy (GDEPT) of
cancer has gained increasing significance during the 20 years since its inception. The astute …
cancer has gained increasing significance during the 20 years since its inception. The astute …
Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives
SR Wilkinson, C Bot, JM Kelly… - Current topics in …, 2011 - ingentaconnect.com
Chagas disease and African slee** sickness are trypanosomal infections that represent
important public health problems in Latin America and Africa, respectively. The restriction of …
important public health problems in Latin America and Africa, respectively. The restriction of …
Extracellular Vesicle–Mediated In Vitro Transcribed mRNA Delivery for Treatment of HER2+ Breast Cancer Xenografts in Mice by Prodrug CB1954 without General …
AV Forterre, JH Wang, A Delcayre, K Kim… - Molecular cancer …, 2020 - AACR
Prodrugs are harmless until activated by a bacterial or viral gene product; they constitute the
basis of gene-delivered prodrug therapies called GDEPT, which can kill tumors without …
basis of gene-delivered prodrug therapies called GDEPT, which can kill tumors without …